Both in Biotechnology
Black Diamond Therapeutics vs Outlook Therapeutics
Over the past year BDTX returned −52.3% and OTLK returned −64.6%; their daily moves had a correlation of 0.02.
BDTX −52.3% OTLK −64.6%Growth of $1, one year, split-adjusted
| Metric | BDTX | OTLK |
|---|---|---|
| Price | $1.81 | $0.4600 |
| Market cap | $104.0M | $112.0M |
| Today | +3.43% | −1.96% |
| 1 month | −6.7% | −22.8% |
| 6 months | −36.9% | +90.3% |
| Year to date | −25.5% | −70.9% |
| 1 year | −53.2% | −63.5% |
| Revenue growth (YoY) | — | −99.4% |
| Gross margin | — | −95.0% |
| Net margin | — | −233554.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $110.5M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 61.5% | 89.0% |
| Short % of float | 11.8% | 39.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).